Concepedia

Chelator Adherence

Chelator Adherence is a construct in clinical pharmacology that denotes the extent to which patients consistently follow prescribed iron chelation therapy regimens to manage transfusional iron overload, distinguished from related adherence concepts by its specific focus on compliance with chelating agents.

20

Publications

666

Citations

131

Authors

82

Institutions

Publications per year

2017–2026

4

Variants

Chelation AdherenceChelation Therapy Adherence

Parents

Publications

20

The challenges of adherence and persistence with iron chelation therapy

John B. Porter, Michael Evangeli, Amal El‐Beshlawy · International Journal of Hematology · 2011 · 66 citations

, , +11

Health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence in<i>β</i>-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: Results from the EPIC Clinical Trial

John B. Porter, Donald K. Bowden, Marina Economou et al. · Anemia · 2012 · 64 citations · Full text

, , +17

Relationship among chelator adherence, change in chelators, and quality of life in Thalassemia

Felicia Trachtenberg, Eric Gerstenberger, Yan Xu et al. · Quality of Life Research · 2014 · 57 citations · Full text

, , +10

Pumping iron: compliance with chelation therapy among young people who have thalassaemia major

Karl Atkin, Waqar Ahmad · Sociology of Health & Illness · 2000 · 46 citations

, , +17

Comparative Effects of Three Iron Chelation Therapies on the Quality of Life of Greek Patients with Homozygous Transfusion-Dependent Beta-Thalassemia

Vasilis Goulas, A. Kourakli-Symeonidis, Charalambos Camoutsis · ISRN Hematology · 2012 · 46 citations · Full text

, , +13

1–5 of 20

Authors

131

  1. JB
    John B. Porter

    University College London, United Kingdom

    3 publications · 145 citations

    3

    h-index

  2. RY
    Robert Yamashita

    Children's Hospital of Philadelphia, United States

    3 publications · 109 citations

    3

    h-index

  3. ME
    Michael Evangeli

    Royal Holloway University of London, United Kingdom

    2 publications · 81 citations

    2

    h-index

  4. AA
    Alexis A. Thompson

    Lurie Children's Hospital, United States

    2 publications · 90 citations

    2

    h-index

  5. CP
    Carole Paley

    Novartis (United States), United States

    2 publications · 68 citations

    2

    h-index

1–5 of 131

Institutions

82

  1. Novartis (United States)

    New York, United States

    4 h-index

    7 publications

    297 citations

  2. University College London

    London, United Kingdom

    3 h-index

    4 publications

    160 citations

  3. CRUK Lung Cancer Centre of Excellence

    Manchester, United Kingdom

    2 h-index

    2 publications

    130 citations

  4. California State University, San Marcos

    San Marcos, United States

    2 h-index

    2 publications

    90 citations

  5. Royal Holloway University of London

    Egham, United Kingdom

    2 h-index

    3 publications

    96 citations

  6. New England Research (United States)

    White River Junction, United States

    2 h-index

    4 publications

    204 citations

  7. Children's Hospital of Philadelphia

    Philadelphia, United States

    2 h-index

    2 publications

    90 citations

  8. New England Research Institutes

    Watertown, United States

    2 h-index

    4 publications

    204 citations

1–8 of 82

Venues

  1. Hemoglobin

    3 publications · 36 citations

    3

    h-index

  2. Value in Health

    1 publications · 35 citations

    1

    h-index

  3. ISRN Hematology

    1 publications · 46 citations

    1

    h-index

  4. Annals of the New York Academy of Sciences

    1 publications · 19 citations

    1

    h-index

  5. British Journal of Haematology

    BJH · 1 publications · 39 citations

    1

    h-index

1–5